Literature DB >> 22486709

Regulation and expression of IL-32 in chronic rhinosinusitis.

M B Soyka1, A Treis, T Eiwegger, G Menz, S Zhang, D Holzmann, C A Akdis, N Meyer.   

Abstract

BACKGROUND: Activated T lymphocytes and their interaction with resident tissue cells, particularly epithelium, play important roles in inflammatory processes in chronic rhinosinusitis (CRS). IL-32 is a recently described cytokine, which is expressed in a variety of tissue cells and involved in the pathogenesis of several chronic inflammatory diseases.
METHODS: Human sinus epithelial cells were isolated from biopsies and stimulated with different cytokines, which play a role in the pathogenesis of CRS. IL-32 mRNA expression was analyzed using real-time-PCR, IL-32 protein was determined by Western blot and flow cytometry as well as immunofluorescent staining in primary sinus epithelial cells and nasal biopsies from patients with CRS and healthy controls.
RESULTS: IL-32 mRNA was upregulated by TNF-α and IFN-γ in primary sinus epithelial cells, whereas IL-1 β, IL-4, IL-13, and IL-17 did not influence IL-32 expression. IL-32 mRNA expression was significantly higher in human primary sinonasal epithelial cells (HSECs) cocultured with Th1 cells compared with HSECs cocultured with Th0 or Th2 cells. IL-32 mRNA expression was significantly higher in biopsies from sinus epithelial tissue of CRS patients with nasal polyps compared with healthy subjects (P = 0.01). IL-32 was detected in biopsies from patients with CRS, whereas it was scarcely present in control tissues.
CONCLUSION: The induction of IL-32 by TNF-α, IFN-γ and Th1 cells as well as its increased expression in sinus tissues from CRS patients with nasal polyps demonstrated a potential role for IL-32 in the pathogenesis of CRS.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22486709     DOI: 10.1111/j.1398-9995.2012.02820.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  17 in total

1.  IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression.

Authors:  Hanako Ohmatsu; Daniel Humme; Juana Gonzalez; Nicholas Gulati; Markus Möbs; Wolfram Sterry; James G Krueger
Journal:  Oncoimmunology       Date:  2016-05-05       Impact factor: 8.110

Review 2.  Novel developments in the mechanisms of immune tolerance to allergens.

Authors:  Thomas Eiwegger; Saskia Gruber; Zsolt Szépfalusi; Cezmi A Akdis
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

3.  Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.

Authors:  Cezmi A Akdis; Claus Bachert; Cemal Cingi; Mark S Dykewicz; Peter W Hellings; Robert M Naclerio; Robert P Schleimer; Dennis Ledford
Journal:  J Allergy Clin Immunol       Date:  2013-04-12       Impact factor: 10.793

Review 4.  Role of interleukin-32 in chronic rhinosinusitis.

Authors:  Anjeni Keswani; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-02

Review 5.  Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways.

Authors:  Norbert Meyer; Cezmi A Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

Review 6.  Novel insights into the biology of interleukin-32.

Authors:  Leo A B Joosten; Bas Heinhuis; Mihai G Netea; Charles A Dinarello
Journal:  Cell Mol Life Sci       Date:  2013-03-06       Impact factor: 9.261

7.  Elevated interleukin-32 expression is associated with Helicobacter pylori-related gastritis.

Authors:  Liu-Sheng Peng; Yuan Zhuang; Wen-Hua Li; Yuan-Yuan Zhou; Ting-Ting Wang; Na Chen; Ping Cheng; Bo-Sheng Li; Hong Guo; Shi-Ming Yang; Wei-San Chen; Quan-Ming Zou
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

8.  The role of N-glycosylation in kiwi allergy.

Authors:  María Garrido-Arandia; Amaya Murua-García; Aranzazu Palacin; Leticia Tordesillas; Cristina Gómez-Casado; Natalia Blanca-Lopez; Tania Ramos; Gabriela Canto; Carlos Blanco; Javier Cuesta-Herranz; Rosa Sánchez-Monge; Luis F Pacios; Araceli Díaz Perales
Journal:  Food Sci Nutr       Date:  2014-03-19       Impact factor: 2.863

9.  Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.

Authors:  Hélio Galdino; Anetícia Eduarda Maldaner; Lívia Lara Pessoni; Frederico M Soriani; Ledice Inácia de Araújo Pereira; Sebastião Alves Pinto; Fernanda Bugalho Duarte; Clayson Moura Gomes; Anna Karoline Aguiar Fleuri; Miriam Leandro Dorta; Milton Adriano Pelli de Oliveira; Mauro Martins Teixeira; Aline Carvalho Batista; Leo A B Joosten; Leda Quercia Vieira; Fátima Ribeiro-Dias
Journal:  BMC Infect Dis       Date:  2014-05-09       Impact factor: 3.090

10.  Interleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification.

Authors:  Yun Sun Park; Jeong-Woo Kang; Dong Hun Lee; Man Sub Kim; Yesol Bak; Young Yang; Hee Gu Lee; JinTae Hong; Do-Young Yoon
Journal:  Oncotarget       Date:  2014-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.